Lymphoblastoid cell lines in pharmacogenomics: How applicable are they to clinical outcomes?

Pharmacogenomics

Volumn 14, Issue 5, 2013, Pages 447-450

  Stark, Amy L ^a   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

cell based model; cytotoxicity; genotype phenotype; lymphoblastoid; pharmacogenetic

Indexed keywords

ANTILEUKEMIC AGENT; CARBOPLATIN; PLATINUM COMPLEX; SIMVASTATIN;

ACUTE GRANULOCYTIC LEUKEMIA; CELL TYPE; DRUG CYTOTOXICITY; DRUG RESPONSE; DRUG SAFETY; EXPERIMENTAL MODEL; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HAPLOTYPE MAP; HEAD AND NECK CANCER; HUMAN; LYMPHOBLASTOID CELL LINE; NONHUMAN; OUTCOME ASSESSMENT; OVARY CANCER; PHARMACOGENOMICS; PREDICTION; REVIEW;

B-LYMPHOCYTES; CELL LINE; HUMANS; PHARMACOGENETICS; TREATMENT OUTCOME;

EID: 84875936052     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.13.32     Document Type: Review

References (22)

1. Welsh M, Mangravite L, Medina MW et al. Pharmacogenomic discovery using cell-based models. Pharmacol. Rev. 61(4), 413-429 (2009
2. Wheeler HE, Dolan ME. Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation. Pharmacogenomics 13(1), 55-70 (2012
3. Mangravite LM, Medina MW, Cui J et al. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin. Arterioscler. Thromb. Vasc. Biol. 30(7), 1485-1492 (2010
4. Ko DC, Gamazon ER, Shukla KP et al. Functional genetic screen of human diversity reveals that a methionine salvage enzyme regulates inflammatory cell death. Proc. Natl Acad. Sci. USA 109(35), e2343-e2352 (2012
5. Smirnov DA, Morley M, Shin E, Spielman RS, Cheung VG. Genetic analysis of radiation-induced changes in human gene expression. Nature 459(7246), 587-591 (2009
6. Zhang W, Duan S, Kistner EO et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am. J. Hum. Genet. 82(3), 631-640 (2008
7. Pickrell JK, Marioni JC, Pai AA et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464(7289), 768-772 (2010
8. Stranger BE, Nica AC, Forrest MS et al. Population genomics of human gene expression. Nat. Genet. 39(10), 1217-1224 (2007 (Pubitemid 47482691)
9. Huang RS, Gamazon ER, Ziliak D et al. Population differences in microRNA expression and biological implications. RNA Biol. 8(4), 692-701 (2011
10. Bell JT, Pai AA, Pickrell JK et al. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol. 12(1), R10 (2011
11. Caliskan M, Cusanovich DA, Ober C, Gilad Y. The effects of EBV transformation on gene expression levels and methylation profiles. Hum. Mol. Gen. 20(8), 1643-1652 (2011
12. French D, Yang W, Cheng C et al. Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia. Blood 113(19), 4512-4520 (2009
13. Ellsworth KA, Moon I, Eckloff BW et al. FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder. Pharmacogen. Genomics 23(3), 156-166 (2013
14. Mitra AK, Crews K, Pounds S et al. Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study. Leukemia 25(8), 1354-1356 (2011
15. Ziliak D, O'Donnell PH, Im HK et al. Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers. Trans. Res. 157(5), 265-272 (2011
16. Huang RS, Johnatty SE, Gamazon ER et al. Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin. Cancer Res. 17(16), 5490-5500 (2011
17. Brown CC, Havener TM, Medina MW et al. A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT. Pharmacogen. Genomics 22(11), 796-802 (2012
18. Medina MW, Gao F, Ruan W, Rotter JI, Krauss RM. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Circulation 118(4), 355-362 (2008
19. Tantisira KG, Lasky-Su J, Harada M et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N. Engl. J. Med. 365(13), 1173-1183 (2011
20. Cox NJ, Gamazon ER, Wheeler HE, Dolan ME. Clinical translation of cell-based pharmacogenomic discovery. Clin. Pharmacol. Ther. 92(4), 425-427 (2012
21. Wheeler HE, Gamazon ER, Wing C et al. Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of paclitaxel-induced sensory peripheral neuropathy. Clin. Cancer Res. 19(2), 491-499 (2013
22. Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat. Methods 7(2), 148-155 (2010